SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Vir Biotechnology to Present ECLIPSE 1 Phase 3 Data at AASLD

Vir Biotechnology plans to present topline ECLIPSE 1 results for elebsiran and tobevibart at AASLD’s 2026 Liver Meeting. A conference call is scheduled to discuss the results and expanded Phase 2 SOLSTICE data.

VIR

Story updates

03:03:07 PM UTC
SquawkNews
Vir Biotechnology Presents Phase 3 ECLIPSE 1 Results at AASLD’s Liver Meeting Vir Biotechnology

Related stories